Company
United StatesPublic company, NASDAQ: CRBUCaribou Biosciences, Inc. (NASDAQ: CRBU), Berkeley, CA – FDA Inspections
Inspection records and compliance data for Caribou Biosciences, Inc. in Berkeley, California. 1 FDA inspection on record, last inspected March 21, 2025. Publicly traded as NASDAQ: CRBU.
Company Profile
This profile covers Caribou Biosciences, Inc. based in Berkeley, California, United States.
FDA Inspection History
- FDA inspections
- 1
- OAI
- 0
- VAI
- 0
- NAI
- 1
- Form 483s
- 0
- Warning letters
- 0
Inspected March 21, 2025.
FDA inspections (1)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| March 21, 2025 | NAI | Biologics · Bioresearch Monitoring | 1264966 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
UC San Diego Health Clinical Lab - La jolla
Spine Squad, Inc.
Sudhir Gupta, M.D., Ph.D., M.A.C.P
AXIS Spine LLC
Southern California Permanente Medical Group
American National Red Cross (The)
Janice Wes Brown, M.D.
Jonathan M. Ducore, MD, MPH
Valley Presbyterian Hospital Blood Bank
Pacific Coast Reproductive Center Inc
Company Information
Name
Caribou Biosciences, Inc.
Stock ticker
CRBU
Exchange
NASDAQ
Share price
$0.41
Market cap
$44.2M
Price as of
November 6, 2026
FEI Number
3033656198
Address
2929 7th St Ste 105, Berkeley, California 94710, United States
Country
United States
ID: 5db71dad-a1e9-4d0a-a26f-4ea7171b57a4